Cargando…
Repurposing Dihydropyridines for Treatment of Helicobacter pylori Infection
Antibiotic resistance is a major cause of the increasing failures in the current eradication therapies against Helicobacter pylori. In this scenario, repurposing drugs could be a valuable strategy to fast-track novel antimicrobial agents. In the present study, we analyzed the inhibitory capability o...
Autores principales: | González, Andrés, Casado, Javier, Chueca, Eduardo, Salillas, Sandra, Velázquez-Campoy, Adrián, Espinosa Angarica, Vladimir, Bénejat, Lucie, Guignard, Jérome, Giese, Alban, Sancho, Javier, Lehours, Philippe, Lanas, Ángel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6969910/ https://www.ncbi.nlm.nih.gov/pubmed/31847484 http://dx.doi.org/10.3390/pharmaceutics11120681 |
Ejemplares similares
-
Small Molecule Inhibitors of the Response Regulator ArsR Exhibit Bactericidal Activity against Helicobacter pylori
por: González, Andrés, et al.
Publicado: (2020) -
Identifying potential novel drugs against Helicobacter pylori by targeting the essential response regulator HsrA
por: González, Andrés, et al.
Publicado: (2019) -
1,4-Dihydropyridine as a Promising Scaffold for Novel Antimicrobials Against Helicobacter pylori
por: González, Andrés, et al.
Publicado: (2022) -
Regulatory T cells may participate in Helicobacter pylori persistence in gastric MALT lymphoma: lessons from an animal model
por: Laur, Amandine Marine, et al.
Publicado: (2015) -
Flavodoxins as Novel Therapeutic Targets against Helicobacter pylori and Other Gastric Pathogens
por: Salillas, Sandra, et al.
Publicado: (2020)